Beyond LDL-cholesterol: New treatments raising HDL-cholesterol or enhancing reverse cholesterol transport

Journal fur Kardiologie

Volumn 9, Issue 7-8, 2002, Pages 328-331

  Kostner, Karam ^a,b  

^a Lipidsciences   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; ATORVASTATIN; CERIVASTATIN; EZETIMIBE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; STATINE DERIVATIVE;

APHERESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DIET RESTRICTION; DIET THERAPY; DRUG INDUCED DISEASE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIPID BLOOD LEVEL; RISK FACTOR;

EID: 0036329255     PISSN: 10240098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Reverse cholesterol transport and atherosclerosis regression
2. Recombinant apolipoproteins for the treatment of vascular diseases
3. Incidence of coronary artery disease and lipoprotein cholesterol levels. The Framingham Study
4. High density lipoprotein cholesterol and cardiovascular disease. Four prospective cardiovascular studies
5. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of HDL-C
6. Comparative dose efficacy study of atorvastation versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolaemia
7. Ezetlmibe: A selective inhibitor of cholesterol absorption
8. Drug treatment of combined hyperlipidemia
9. New combination niacin/statin formulation shows pronounced effects on major lipoproteins and is well tolerated
10. Lecithin-cholesterol acyltransferase activity in normocholesterolaemic and hypercholesterolaemic roosters: Modulation by lipid apheresis
11. A solvent system for delipidation of plasma or serum without protein precipitation
12. Lipid apheresis in an animal model causes acute reduction in plasma lipid concentrations and mobilisation of lipid from liver and aorta
13. Lipid apheresis. An in vivo application of plasma delipidation with organic solvents resulting in acute transient reduction of circulating plasma lipids in animals
14. Lipid apheresis in an animal model causes in vivo changes in lipoprotein electrophoretic patterns
15. Intravenous apoA-I/lecithin discs increase prebeta HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans
16. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I